Congress Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-197,312
| Closed | -$661K | – | 375 |
|
|
2023
Q1 | $661K | Buy |
197,312
+19,400
| +11% | +$65K | 0.01% | 317 |
|
|
2022
Q4 | $856K | Buy |
177,912
+2,039
| +1% | +$9.81K | 0.01% | 314 |
|
|
2022
Q3 | $1M | Buy |
175,873
+1,830
| +1% | +$10.4K | 0.01% | 302 |
|
|
2022
Q2 | $1.24M | Sell |
174,043
-7,092
| -4% | -$50.4K | 0.01% | 308 |
|
|
2022
Q1 | $1.31M | Buy |
181,135
+13,449
| +8% | +$97.1K | 0.01% | 309 |
|
|
2021
Q4 | $1.5M | Sell |
167,686
-15
| -0% | -$134 | 0.01% | 304 |
|
|
2021
Q3 | $5.88M | Buy |
167,701
+13,435
| +9% | +$471K | 0.05% | 214 |
|
|
2021
Q2 | $3.31M | Buy |
154,266
+113,891
| +282% | +$2.45M | 0.03% | 244 |
|
|
2021
Q1 | $2.49M | Buy |
40,375
+7,365
| +22% | +$455K | 0.02% | 248 |
|
|
2020
Q4 | $1.38M | Buy |
+33,010
| New | +$1.38M | 0.01% | 261 |
|